Members of the TIMNano research team participated in the 2025 Controlled Release Society (CRS) Annual Meeting, one of the leading international events dedicated to drug delivery, nanomedicine and translational pharmaceutical research.
The conference brought together scientists, clinicians, industry representatives and innovators from around the world to discuss the latest advances in drug delivery technologies, biomaterials, immunotherapies and precision medicine.
During the event, researchers involved in TIMNano presented their work, engaged with the international scientific community and contributed to discussions on emerging approaches in nanomedicine and cancer treatment.
Participation in scientific conferences such as CRS plays an important role in the dissemination of research activities, enabling knowledge exchange, fostering collaborations and ensuring that innovative projects remain connected to the broader scientific ecosystem.
The themes addressed during CRS 2025—including targeted drug delivery, immune modulation and translational nanomedicine—are closely aligned with the scientific objectives of TIMNano and its efforts to develop innovative nano-immunotherapy strategies for gastrointestinal cancers.
